期刊文献+

心力衰竭患者心肌组织β_1、β_2、β_3受体mRNA表达改变与心功能的关系 被引量:11

The relationship between expressions of β_1-,β2-,β _3-adrenoceptor mRNA of myocardium and cardiac function in patients with heart failure
原文传递
导出
摘要 目的 探讨不同程度心力衰竭(心衰)患者心肌组织β1、β2、β3 受体mRNA表达的变化及其与心功能的关系。方法 应用逆转录聚合酶链反应方法检测24例瓣膜置换术的心衰患者和5例健康对照者心肌组织β1、β2、β3 受体mRNA表达。结果 心衰时β1 受体mRNA表达减少,心衰程度越重表达越少;β2 受体表达在不同程度心衰患者之间改变差异无统计学意义;β3 受体表达增多,心衰程度越重表达越多。结论 心衰时β1 受体下调,而β3 受体上调,心肌组织β受体mRNA的变化与心功能密切相关。 Objective To investigate the alteration of expressions of β 1-,β 2-,β 3-adrenoceptor mRNA in human myocardial tissue and the relation between their expressions and cardiac function in patient with heart failure. Methods The mRNA expressions of β 1-,β 2- and β 3-adrenergic receptors in myocardial tissue were analyzed by using the reverse transcriptase-polymerase chain reaction in 24 patients with heart failure of valvular heart disease and 5 control subjects.Results β 1-adrenergic receptor mRNA expressions in myocardium were significantly lower in patients with heart failure than those in control subjects, and progressively reduced with aggravation of heart function. By contrast, β 3-adrenoceptor mRNA expressions were significantly higher in patients with heart failure than those in controls, and progressively elevated with aggravation of cardiac function. No difference was observed in β 2-adrenergic receptor among all groups.Conclusion The changes of β-adrenergic receptor mRNA expression are associated with the severity of heart failure.
出处 《中华心血管病杂志》 CAS CSCD 北大核心 2005年第4期351-353,共3页 Chinese Journal of Cardiology
  • 相关文献

参考文献9

  • 1王江 祝善俊 祝善俊 徐成斌 主编.神经激素受体与心力衰竭[A].祝善俊,徐成斌,主编.心力衰竭基础与临床.第1版[C].北京:人民军医出版社,2001.90.
  • 2Bristow MR, Ginsburg R, Minobe W, et al. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N Engl J Med, 1982,307:205-211.
  • 3Bristow MR, Anderson FL, Port JD, et al. Differences in beta-adrenergic neuroeffector mechanisms in ischemic versus idiopathic dilated cardiomyopathy. Circulation, 1991, 84: 1024-1039.
  • 4Ihl-Vahl R, Eschenhagen T, Kubler W, et al. Differential regulation of mRNA specific for beta1- and beta2-adrenergic receptors in human failing hearts: evaluation of the absolute cardiac mRNA levels by two independent methods. J Mol Cell Cardiol, 1996,28:1-10.
  • 5Bristow MR, Ginsburg R, Umans V, et al. Beta1- and beta2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta1-receptor down-regulation in heart failure. Circ Res, 1986,59:297-309.
  • 6Brodde OE. Beta1- and beta2-adrenoceptors in human heart: properties, function, and alterations in chronic heart failure. Pharmacol Rev, 1991,43:203-242.
  • 7Moniotte S, Kobzik L, Feron O, et al. Upregulation of beta3-adrenoceptors and altered contractile response to inotropic amines in human failing myocardium. Circulation, 2001,103:1649-1655.
  • 8Cheng CP, Tomhiko U, Onishi K, et al. Beta3-adrenergic activation-induced enhanced cardiac depression in heart failure: assessment by left ventricle-pressure volume analysis. Circulation, 1999,100(Suppl):552.
  • 9Ghantal C, Langin D, Balligand JL. Beta3-adrenoceptors in the cardiovascular system. Trend Pharma Science, 2000,21:426-431.

共引文献1

同被引文献103

引证文献11

二级引证文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部